Sameer Ralhan - 01 Mar 2023 Form 4/A - Amendment Insider Report for Chemours Co (CC)

Role
SVP, CFO
Signature
/s/ Pauletta Brown, Attorney-in-Fact
Issuer symbol
CC
Transactions as of
01 Mar 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
10 Mar 2023, 12:50
Date Of Original Report
03 Mar 2023
Previous filing
14 Feb 2023
Next filing
02 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CC Performance Stock Option (Right to Buy) Award $0 +28.8K $0.00 28.8K 01 Mar 2023 Common Stock 28.8K $38.32 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a 10 percent premium above the closing price of the Company common stock on the date of grant
F2 The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.
F3 These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.